Research Reference
GLP-1 Compound Comparison
A side-by-side reference of the most actively researched GLP-1 class peptides available at NUVU Science. All compounds are research-grade, ≥99% purity, third-party verified.
| Property | AOD-9604 | Cagrilintide | New Retatrutide | Best Seller Semaglutide | Top Rated Tirzepatide |
|---|---|---|---|---|---|
| Mechanism | hGH fragment (176–191) | Long-acting amylin analogue | Triple GLP-1/GIP/glucagon agonist | GLP-1 agonist | Dual GIP/GLP-1 agonist |
| Half-Life | ~30 min | ~7 days | ~6 days | ~7 days | ~5 days |
| Receptor Targets | β3-adrenergic receptor (proposed) | Amylin receptors (CALCR/RAMP) | GLP-1R + GIPR + GCGR | GLP-1R | GLP-1R + GIPR |
| Research Focus | Fat metabolism, lipolysis, no IGF-1 elevation in models | Amylin pathway, satiety signaling, combination GLP-1 research | Triple receptor agonism, cutting-edge metabolic & energy expenditure research | Metabolic regulation, appetite suppression, insulin secretion | Dual receptor metabolic research, superior weight reduction studies |
| Purity | ≥99% | ≥99% | ≥99% | ≥99% | ≥99% |
| Starting Price | From $45 | From $60 | From $115 | From $55 | From $95 |
| Product links | View Product | View Product | View Product | View Product | View Product |
All compounds are for research use only. Not for human or veterinary use. Data sourced from published preclinical and clinical literature.